| Imaging synaptic density in the living human brain SJ Finnema, NB Nabulsi, T Eid, K Detyniecki, S Lin, MK Chen, R Dhaher, ... Science translational medicine 8 (348), 348ra96-348ra96, 2016 | 416 | 2016 |
| Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study M Slifstein, E Van De Giessen, J Van Snellenberg, JL Thompson, ... JAMA psychiatry 72 (4), 316-324, 2015 | 414 | 2015 |
| Assessing synaptic density in Alzheimer disease with synaptic vesicle glycoprotein 2A positron emission tomographic imaging MK Chen, AP Mecca, M Naganawa, SJ Finnema, T Toyonaga, S Lin, ... JAMA neurology 75 (10), 1215-1224, 2018 | 363 | 2018 |
| Imaging robust microglial activation after lipopolysaccharide administration in humans with PET CM Sandiego, JD Gallezot, B Pittman, N Nabulsi, K Lim, SF Lin, ... Proceedings of the National Academy of Sciences 112 (40), 12468-12473, 2015 | 333 | 2015 |
| Lower synaptic density is associated with depression severity and network alterations SE Holmes, D Scheinost, SJ Finnema, M Naganawa, MT Davis, ... Nature communications 10 (1), 1529, 2019 | 330 | 2019 |
| Synthesis and preclinical evaluation of 11C-UCB-J as a PET tracer for imaging the synaptic vesicle glycoprotein 2A in the brain NB Nabulsi, J Mercier, D Holden, S Carré, S Najafzadeh, ... Journal of Nuclear Medicine 57 (5), 777-784, 2016 | 238 | 2016 |
| In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET AP Mecca, MK Chen, RS O'Dell, M Naganawa, T Toyonaga, TA Godek, ... Alzheimer's & Dementia 16 (7), 974-982, 2020 | 191 | 2020 |
| The neuroinflammation marker translocator protein is not elevated in individuals with mild-to-moderate depression: a [11C] PBR28 PET study J Hannestad, N DellaGioia, JD Gallezot, K Lim, N Nabulsi, I Esterlis, ... Brain, behavior, and immunity 33, 131-138, 2013 | 184 | 2013 |
| Sex differences in the brain's dopamine signature of cigarette smoking KP Cosgrove, S Wang, SJ Kim, E McGovern, N Nabulsi, H Gao, ... Journal of Neuroscience 34 (50), 16851-16855, 2014 | 176 | 2014 |
| Kinetic evaluation and test–retest reproducibility of [11C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A … SJ Finnema, NB Nabulsi, J Mercier, S Lin, MK Chen, D Matuskey, ... Journal of Cerebral Blood Flow & Metabolism 38 (11), 2041-2052, 2018 | 167 | 2018 |
| Brivaracetam, a selective high‐affinity synaptic vesicle protein 2A (SV 2A) ligand with preclinical evidence of high brain permeability and fast onset of action JM Nicolas, J Hannestad, D Holden, S Kervyn, N Nabulsi, D Tytgat, ... Epilepsia 57 (2), 201-209, 2016 | 149 | 2016 |
| PET imaging of the effects of age and cocaine on the norepinephrine transporter in the human brain using (S,S)‐[11C]O‐methylreboxetine and HRRT YS Ding, T Singhal, B Planeta‐Wilson, JD Gallezot, N Nabulsi, D Labaree, ... Synapse 64 (1), 30-38, 2010 | 137 | 2010 |
| Synaptic changes in Parkinson disease assessed with in vivo imaging D Matuskey, S Tinaz, KC Wilcox, M Naganawa, T Toyonaga, M Dias, ... Annals of neurology 87 (3), 329-338, 2020 | 134 | 2020 |
| Altered metabotropic glutamate receptor 5 markers in PTSD: In vivo and postmortem evidence SE Holmes, MJ Girgenti, MT Davis, RH Pietrzak, N DellaGioia, N Nabulsi, ... Proceedings of the National Academy of Sciences 114 (31), 8390-8395, 2017 | 124 | 2017 |
| Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [11C]-(+)-PHNO RR Girgis, M Slifstein, D D’Souza, Y Lee, A Periclou, P Ghahramani, ... Psychopharmacology 233, 3503-3512, 2016 | 123 | 2016 |
| Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [11C] ABP688 and PET imaging study in depression I Esterlis, N DellaGioia, RH Pietrzak, D Matuskey, N Nabulsi, CG Abdallah, ... Molecular psychiatry 23 (4), 824-832, 2018 | 121 | 2018 |
| PET imaging of synaptic density: a new tool for investigation of neuropsychiatric diseases Z Cai, S Li, D Matuskey, N Nabulsi, Y Huang Neuroscience letters 691, 44-50, 2019 | 110 | 2019 |
| The effect of early trauma exposure on serotonin type 1B receptor expression revealed by reduced selective radioligand binding JW Murrough, C Czermak, S Henry, N Nabulsi, JD Gallezot, ... Archives of general psychiatry 68 (9), 892-900, 2011 | 110 | 2011 |
| In vivo ketamine-induced changes in [11C] ABP688 binding to metabotropic glutamate receptor subtype 5 C DeLorenzo, N DellaGioia, M Bloch, G Sanacora, N Nabulsi, C Abdallah, ... Biological psychiatry 77 (3), 266-275, 2015 | 100 | 2015 |
| Clinical doses of atomoxetine significantly occupy both norepinephrine and serotonin transports: Implications on treatment of depression and ADHD YS Ding, M Naganawa, JD Gallezot, N Nabulsi, SF Lin, J Ropchan, ... Neuroimage 86, 164-171, 2014 | 95 | 2014 |
